C 022: THE GUANINE-BASED PURINERGIC SYSTEM AS A NEW TARGET FOR NEUROPROTECTION AGAINST GLUTAMATERGIC EXCYTOTOXICITY

Excerpt:


J Pharm Pharmacogn Res 2(Suppl. 1): S65, 2014 Special supplement with the abstract book of LATINFARMA 2013 Conference C 022: THE GUANINE-BASED PURINERGIC SYSTEM AS A NEW TARGET FOR NEUROPROTECTION AGAINST GLUTAMATERGIC EXCYTOTOXICITY Souza DO. Departamento de Bioquímica, PPG em Bioquímica e PPG em Educação em Ciências, ICBS, UFRGS. Rua Ramiro Barcelos, 2600 – Anexo. … Continue reading C 022: THE GUANINE-BASED PURINERGIC SYSTEM AS A NEW TARGET FOR NEUROPROTECTION AGAINST GLUTAMATERGIC EXCYTOTOXICITY

J Pharm Pharmacogn Res 2(Suppl. 1): S65, 2014

Special supplement with the abstract book of LATINFARMA 2013

Conference

C 022: THE GUANINE-BASED PURINERGIC SYSTEM AS A NEW TARGET FOR NEUROPROTECTION AGAINST GLUTAMATERGIC EXCYTOTOXICITY

Souza DO.

Departamento de Bioquímica, PPG em Bioquímica e PPG em Educação em Ciências, ICBS, UFRGS. Rua Ramiro Barcelos, 2600 – Anexo. CEP: 90035-003, Porto alegre, RS, Brazil.
Abstract

Glutamate is the main excitatory neurotransmitter in mammalian CNS, essential for brain activities, as those involved in development, ageing, memory, and adaptation to the environment. However, hyper activation of the glutamatergic system may be potentially neurotoxic, involved in the pathogenesis of various acute and chronic brain injuries. The main process responsible by maintaining the extracellular glutamate levels below toxic levels, thus favoring the physiological glutamatergic tonus, is the glutamate uptake exerted by transporters located in neural cell membranes, mainly in astrocytes. Our group has given strong evidence that the guanine-based purinergic system is effectively neuroprotective against glutamate toxicity, in acute and chronic animal models, both in vitro and in vivo studies. Our results indicate that nucleoside guanosine (Guo) exerts neuroprotection. In vivo Guo i.c.v., i.p. or orally administered in rodents protects against brain injury caused by overstimulation of the glutamatergic system. In vitro studies, Guo protects cell death in brain slices caused by in vitro ischemia. Searching for mechanisms implicated in this neuroprotection, we demonstrated that: i) Guo stimulates the astrocytic glutamate uptake (in astrocyte cultures and brain slices), the main process involved in endogenous neuronal protection; ii) brain induced-injuries decrease glutamate uptake by brain slices and this decrease is reversed by Guo only when it acts as anticonvulsant; iii) brain oxidative stress caused by glutamate toxicity in experimental brain injury models is reversed by Guo administration. Thus we propose that the stimulatory effect on glutamate uptake and/or its antioxidant activity are involved in the neuroprotective actions of Guo. These results encourage further studies aiming at the therapeutic use in humans of Guo in acute (hypoxia, ischemia, brain traumatism) and chronic (neurodegenerative diseases) brain injuries involving glutamate excytotoxicity.

Ageratum conyzoides and eggshell membrane hydrolysates in chronic inflammation
J. Pharm. Pharmacogn. Res., vol. 12, no. 5, pp. 972-993, Sep-Oct 2024. DOI: https://doi.org/10.56499/jppres24.1956_12.5.972 Original Article Anti-inflammatory effect of the mixture of Ageratum conyzoides L. extract and eggshell membrane hydrolysates and in silico active compound predictions [Efecto antiinflamatorio de la mezcla de extracto de Ageratum conyzoides L. e hidrolizados de membrana de cáscara de huevo, … Continue reading Ageratum conyzoides and eggshell membrane hydrolysates in chronic inflammation
SS-31 for diabetic nephropathy
J. Pharm. Pharmacogn. Res., vol. 12, no. 5, pp. 956-971, Sep-Oct 2024. DOI: https://doi.org/10.56499/jppres23.1904_12.5.956 Review SS-31 protects diabetic nephropathy progression: A systematic review of in vivo and in vitro studies [El SS-31 protege la progresión de la nefropatía diabética: Una revisión sistemática de estudios in vivo e in vitro] Jonathan Christianto Sutadji1#, Dian Anggraini Permatasari … Continue reading SS-31 for diabetic nephropathy
Hypertension knowledge and its associated factors in primary care
J. Pharm. Pharmacogn. Res., vol. 12, no. 5, pp. 943-955, Sep-Oct 2024. DOI: https://doi.org/10.56499/jppres24.1955_12.5.943 Original Article Hypertension knowledge and its associated factors among hypertensive patients in primary care settings in Central Vietnam: A cross-sectional study [Conocimiento de la hipertensión y sus factores asociados entre pacientes hipertensos en entornos de atención primaria en el centro de … Continue reading Hypertension knowledge and its associated factors in primary care

© 2013-2020 by the authors; licensee JPPRes, Antofagasta, Chile. This journal is an open-access journal distributed under the terms and conditions of the Creative Commons Attribution license-Non Commercial 4.0 international. The content on this site is intended for health professionals. If you are not a health professional, please talk to your doctor about any doubts or concerns regarding your health

Made with ♥ by AVAGAX Studio